Investment analysts at B. Riley issued their Q1 2025 earnings estimates for shares of OptimizeRx in a note issued to ...
Shares of Teleflex Inc. TFX advanced 1.48% to $139.75 Monday, on what proved to be an all-around favorable trading session ...
Nurix on Monday said the FDA granted orphan-drug designation to bexobrutideg, also known as NX-5948, for the treatment of Waldenstrom macroglobulinemia, a slow growing type of non-Hodgkin's lymphoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback